Phase Iii Trial Of Denosumab For Breast Cancer Risk Reduction In Brca1 Carriers

Phase III trial of denosumab for breast cancer risk reduction in BRCA1 carriers

Denosumab Study for Preventing Breast Cancer in BRCA1

Carolina Breast Friends - Breast Cancer Support

Clinical Trial Available for Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

UT Health San Antonio MD Anderson Cancer Center

Disparities in cancer risk management among BRCA carriers

Considerations facing young women with a BRCA mutation

Women's College Hospital

Risk Modifiers for BRCA Carriers

Breast Cancer Research Foundation

Learn all about BRCA mutations that help detect risk of breast cancer #fightcancerwithonco

Phase III results of olaparib for BRCA breast cancer

The ABCs of Cancer Risk: Understanding What Risk Means for BRCA Mutation Carriers

Basser Center for BRCA

Phase 3 Trial Investigates T-DM1 and Pertuzumab in HER2+ Breast Cancer

Targeted Oncology

Role of BRCA Mutations in BC

AZ Precision Medicine

An Overview of the MA17R Trial in Breast Cancer

Targeted Oncology

What are the BRCA 1 and 2 genes and how do mutations effect me? with Ddr Tasha

BRCA1: Genetic Risk for Breast Cancer

Endeavor Health

Managing your risk of breast and ovarian cancer

Women's College Hospital

Safety outcomes in the Phase III monarchE trial of abemaciclib + ET in HR+, HER2- breast cancer

BRCA Workshop | Risk-Reducing Surgeries for Breast and Ovarian Cancer: Options and Timing

Identification of the BRCA1 and BRCA2 Genes - Breast Cancer Trials

Breast Cancer Trials

Genetics of Breast Cancer and Risk Reducing Mastectomy

Women's College Hospital

Understanding BRCA Mutations and Preventative Double Mastectomies

Breast Implant Illness with Dr. Robert Whitfield